Team AcumenSphere
|Last Updated: August 26, 2026
|Publish Date: August 24, 2026
A pre-revenue startup has no cash flow to discount. Here is what investors calculate instead.
A startup with no revenue has no cash flow to discount, no earnings to multiply, and often no direct public comparable. Standard business valuation tools break down at exactly the stage where founders need a number the most. This article covers what investors actually calculate instead: the Berkus Method, the Scorecard Method, and the Venture Capital Method, each worked with real numbers. It also covers how the primary method shifts once a startup starts generating revenue.
What Is Startup Valuation?
Startup valuation is the process of estimating what an early-stage company is worth, typically to set the terms of a funding round. Unlike an established business, a startup usually lacks the historical financials that standard valuation methods depend on, which is why pre-revenue and early-revenue companies are valued using a different toolkit entirely.
Pre-Money and Post-Money: The Two Numbers Every Round Produces
Every priced funding round produces two figures: the value of the company before new money comes in, and the value after. Investor ownership percentage is always calculated against the post-money figure, not the pre-money one. The full mechanics of pre-money and post-money valuation are covered in a companion piece on this site, including how an option pool can quietly shift how much value the pre-money number actually protects.
How Startup Valuation Changes by Stage
Stage | What's typically available | Common primary method(s) |
Pre-seed | Idea, team, no product | Berkus Method |
Seed | Early prototype, little or no revenue | Berkus, Scorecard |
Series A | Product-market fit, early revenue | Venture Capital Method, revenue multiple |
Series B | Scaling revenue | Revenue multiple, early DCF |
Series C and later | Predictable growth, real cash flow | DCF, market comparables |
Many pre-seed and seed rounds are raised through SAFEs and convertible notes rather than a priced equity round. That delays setting a fixed valuation until a later conversion event, which changes the mechanics but not the underlying question of what the company is worth.
The Berkus Method: Valuing a Startup With No Revenue
Developed by investor Dave Berkus, this method skips revenue entirely. Instead, it assigns a dollar value to five factors that reduce specific risks facing the business. Each factor is typically capped, commonly at $500,000, and the total across all five is the estimated pre-money valuation.
Worked example
Risk-reduction factor | What it addresses | Assigned value |
Sound idea | Basic value of the concept | $400,000 |
Prototype | Reduces technology risk | $350,000 |
Quality management team | Reduces execution risk | $450,000 |
Strategic relationships | Reduces market risk | $250,000 |
Product rollout or early sales | Reduces production risk | $200,000 |
Total pre-money valuation | $1,650,000 |
A strong team and a working prototype move the largest share of this total — which is exactly why early-stage investors weight founding-team quality so heavily even before any revenue exists.
The Scorecard Method: Valuing a Startup Against Its Peers
The Scorecard Method (also called the Bill Payne method) starts with a benchmark. That benchmark is the average pre-money valuation of similar pre-revenue startups in the same region and sector. It then adjusts that figure up or down, based on how the specific startup compares across several weighted factors.
Worked example
Factor | Weight | Comparison rating | Weighted contribution |
Management team | 30% | 120% (above average) | 36.0% |
Market size | 25% | 110% (above average) | 27.5% |
Product/technology | 25% | 90% (below average) | 22.5% |
Competition | 20% | 100% (average) | 20.0% |
Sum of weighted factors | 106.0% |
Amount | |
Regional benchmark pre-money valuation | $2,000,000 |
Adjustment factor | 1.06 |
Adjusted valuation | $2,120,000 |
The startup in this example lands 6% above the regional benchmark, driven mainly by an above-average team and market opportunity that more than offset a below-average product rating.
The Venture Capital Method: Working Backward From an Exit
Once a startup has enough of a growth story to project a plausible exit, investors often work backward from that exit value rather than forward from current metrics. This is the standard approach behind most Series A and later term sheets. It directly determines pre-money and post-money valuation for the round.
Post-money valuation = Projected exit value ÷ Required return multiple
Worked example
Step | Calculation | Result |
Projected exit value (Year 5) | $60,000,000 | |
Required return multiple | 10x | |
Post-money valuation today | $60,000,000 ÷ 10 | $6,000,000 |
Because later funding rounds will dilute this investor's stake before the exit actually happens, the required ownership percentage today needs to be higher than the investor's target ownership at exit:
Step | Calculation | Result |
Target ownership at exit | 15.0% | |
Expected future dilution before exit | 35.0% | |
Required ownership today | 15% ÷ (1 − 0.35) | 23.1% |
Investment required | 23.1% × $6,000,000 | ≈ $1.38M |
Pre-money valuation | $6,000,000 − $1.38M | ≈ $4.62M |
Skipping the dilution adjustment is one of the most common errors made when applying this method — without it, an investor systematically ends up owning less of the company at exit than their return target assumed.
How the required return multiple changes the result
Holding the exit value and dilution assumptions constant, the return multiple investors demand for the risk of an early-stage deal has an outsized effect on today's valuation:
Required return multiple | Post-money valuation today | Pre-money valuation |
5x | $12.00M | ≈ $9.23M |
10x (base case) | $6.00M | ≈ $4.62M |
15x | $4.00M | ≈ $3.08M |
20x | $3.00M | ≈ $2.31M |
A seed-stage investor demanding 20x for the risk they're taking arrives at a pre-money valuation about a quarter of what a 5x return target would support — on the exact same company, with the exact same exit assumption.
Common Valuation Methods by Stage
Method | Best suited to | What it needs |
Berkus Method | Pre-seed, pre-revenue | Team, prototype, strategic relationships |
Scorecard Method | Pre-seed, seed | A regional benchmark valuation to adjust from |
Venture Capital Method | Seed through Series A/B | A credible exit scenario and target return |
Revenue multiple | Series A and later, with real revenue | Comparable company multiples |
Discounted cash flow | Series C and later | Predictable, forecastable cash flow |
As a company matures past the stage where these qualitative and forward-looking methods apply, valuation shifts again. It increasingly relies on a discounted cash flow model, built on the company's own projected cash flows rather than an exit assumption.
Why Startup Valuation Matters Beyond the Funding Round
- Equity dilution. Every dollar raised at a given valuation determines exactly how much ownership founders and existing investors give up.
- Signal for future rounds. A round's valuation sets the bar the next round is expected to clear, and a down round carries real signaling cost.
- Option pool sizing. A valuation that is quoted pre-money but pairs with a large post-money option pool can shift real founder ownership more than the headline number suggests.
- 409A compliance. For US startups issuing equity compensation, a separate, IRS-defensible fair market value is required regardless of what a funding round's valuation says — a 409A valuation for a startup with no revenue yet uses its own distinct methodology.
Common Startup Valuation Mistakes
- Anchoring only on the idea. An idea alone rarely moves the Berkus total past its first factor — team, prototype, and relationships carry most of the weight.
- Ignoring the future-dilution adjustment in the Venture Capital Method, which systematically understates the ownership an investor actually needs today.
- Comparing against unrelated startups when applying the Scorecard Method — the benchmark only holds if the comparable set is genuinely similar in stage, sector, and region.
- Treating a SAFE's valuation cap as a real valuation. SAFEs and convertible notes defer the actual valuation decision to a future priced round; the cap is a ceiling, not a conclusion.
Frequently Asked Questions
How do you value a startup with no revenue?
Pre-revenue startups are typically valued using qualitative methods. The Berkus Method assigns a dollar value to specific risk-reduction factors like the team, prototype and strategic relationships. The Scorecard Method instead adjusts a regional benchmark valuation up or down, based on how the startup compares to similar companies.
What is the Berkus Method?
The Berkus Method values a pre-revenue startup across five risk-reduction factors: a sound idea, a working prototype, a quality management team, strategic relationships, and product rollout or early sales. Each is assigned a dollar amount, typically up to $500,000. The total across all five is the estimated pre-money valuation.
What is the Venture Capital Method?
The Venture Capital Method starts with a projected exit value and divides it by the investor's required return multiple to get today's post-money valuation. Subtracting the investment amount from that figure gives the pre-money valuation. It is commonly adjusted for expected dilution from future funding rounds.
How does startup valuation change by funding stage?
Pre-seed and seed valuations rely on qualitative methods like Berkus and Scorecard since there is little or no revenue. As a startup reaches Series A and beyond with real revenue, valuation shifts toward the Venture Capital Method, revenue multiples, and eventually discounted cash flow once cash flows become predictable.
How do you calculate the valuation of a startup?
The calculation depends on the startup's stage. Pre-revenue companies are typically valued by summing risk-reduction factors (Berkus) or adjusting a benchmark valuation (Scorecard). Revenue-generating startups are more often valued using a revenue multiple, the Venture Capital Method, or discounted cash flow.
Get a Defensible Startup Valuation
A term sheet's valuation is a negotiating position, and a Berkus or Scorecard estimate is a useful starting framework. Neither is a substitute for a formal valuation when one is actually required — for a priced round, a 409A filing, or a strategic decision.
If you want to get a defensible startup valuation for your specific stage and situation, contact our team.
